These lipids are noticeably elevated in ascitic fluid obtained from ovarian cancer patients compared to non-malignant controls (Xiao et al. 2001), suggesting a role for GPR55 in ovarian cancer. This evidence concerns the gene GPR55 and ovarian carcinoma.